Exclusive special offer and discount title banner vector image

ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Asia-Pacific Cellulite Treatment Market by Procedure (Non-invasive, Minimally Invasive, Topical) Market by Type (Soft Cellulite, Hard Cellulite, Edematous Cellulite) Market by End-user (Hospitals, Clinics and Beauty Centers, Other End-users) by Geography


MARKET OVERVIEW

The Asia-Pacific cellulite treatment market is evaluated to develop with a CAGR of 9.78% during the forecasted period of 2023-2032, acquiring a revenue share of $1205.49 million by 2032.

Some of the top drivers linked to the market growth of the region are the presence of skilled professionals, high quality healthcare facilities, as well as the lower cost of treatments and premium medical services. Furthermore, the increasing number of cosmetic procedures performed is set to play an essential role in fueling the market demand, as well. However, the Asia-Pacific cellulite treatment market will likely be obstructed by the high costs associated with cellulite treatment.

To Know More About This Report, Request a Free Sample Copy

The Asia-Pacific cellulite treatment market growth evaluation comprises the assessment of China, Japan, India, Australia & New Zealand, South Korea, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific. According to the International Society of Aesthetic Plastic Surgery (ISAPS), China had around 3,000 plastic surgeons in the year 2021. Moreover, as per the estimates issued by the International Trade Administration (ITA), the retail sales value of cosmetics in the country equated to $52.3 billion in 2020. China also has one of the largest beauty and personal care sectors, with the industry’s significant growth mainly accredited to the rising demand for premium products. Hence, factors such as the presence of a large number of skilled professionals, the increasing number of local and international market players, and the rising beauty standards are expected to play an important part in fueling the demand for cellulite treatments in China. 

On the other hand, as per a survey conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), more than 1,745,600 aesthetic procedures were performed in Japan in 2021. These included 122,696 non-surgical fat reduction procedures as well as 1,166 cellulite treatments. Additionally, the availability of quality healthcare services and cosmetic procedures in Japan is further set to contribute to the growing demand for cellulite treatments. Therefore, the abovementioned factors are anticipated to reinforce the market growth in the Asia-Pacific during the forecasted period.

The Asia-Pacific cellulite treatment market is segmented into procedure, type, and end-user. The end-user segment includes hospitals, clinics and beauty centers, and others. Hospitals comprise an integrated facility of minimally invasive as well as non-invasive devices, with managements aiming to employ high-tech equipment in order to provide advanced treatment facilities. Accordingly, the swift adoption of advanced technologies, coupled with the rising demand for cellulite treatment, is set to augment the segment’s growth over the upcoming years.

Furthermore, the increasing prevalence of healthcare tourism for body sculpting as well as skincare is also expected to create lucrative growth opportunities for hospitals. In addition, an important key factor propelling the growth of the hospitals segment includes the high inclination toward painless treatment procedures.

Prominent companies operating in the Asia-Pacific cellulite treatment market include Nubway Co Ltd, Johnson & Johnson, AbbVie Inc, etc.

Nubway Co Ltd, headquartered in China, manufactures OEMs and ODMs in the field of beauty equipment. The company offers beauty machines for various applications, including hair removal, skin tightening and wrinkle removal, pigment and tattoo removal, skin rejuvenation and anti-aging, body shaping and slimming, and others.

The company’s Portable Microneedle Machine FR III delivers a controlled thermal effect to activate collagen while enhancing skin tightening. The machine also has precise targeting with adjustable microneedles over 3mm. 

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Procedure, Type, End-User
Countries AnalyzedChina, Japan, India, Australia & New Zealand, South Korea, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
Companies AnalyzedJohnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, Cutera Inc, Inceler Medikal Co Ltd, Zimmer MedizinSysteme, Galderma SA, Sientra Inc, Endo International PLC, Candela Corporation, Nubway Co Ltd, Sinclair Pharma, Cynosure LLC, Merz Pharma GmbH & Co KGaA, Alma Lasers

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
    5. MAJOR MARKET FINDINGS
      1. RISING BEAUTY CONSCIOUSNESS
      2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
      3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
      4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
      2. RISING CASES OF OBESITY
      3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
    2. KEY RESTRAINTS
      1. HIGH COST OF ADVANCED CELLULITE TREATMENT
      2. SIDE EFFECTS POST-TREATMENT
      3. LACK OF AWARENESS 
  4. KEY ANALYTICS
    1. PARENT MARKET ANALYSIS
    2. KEY TECHNOLOGY TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING
    5. MARKET MATURITY ANALYSIS
    6. MARKET CONCENTRATION ANALYSIS
    7. VALUE CHAIN ANALYSIS
      1. RESEARCH AND DEVELOPMENT
      2. PRODUCT DEVELOPMENT
      3. MARKETING AND DISTRIBUTION
      4. POST-SALES MONITORING
    8. KEY BUYING CRITERIA
      1. COST
      2. BRAND REPUTATION
      3. USABILITY
  5. MARKET BY PROCEDURE
    1. NON-INVASIVE
    2. MINIMALLY INVASIVE
    3. TOPICAL
  6. MARKET BY TYPE
    1. SOFT CELLULITE
    2. HARD CELLULITE
    3. EDEMATOUS CELLULITE
  7. MARKET BY END-USER
    1. HOSPITALS
    2. CLINICS AND BEAUTY CENTERS
    3. OTHER END-USERS
  8. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
      3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
      4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        5. THAILAND
          1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        6. INDONESIA
          1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABBVIE INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      2. ALMA LASERS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      3. BAUSCH HEALTH COMPANIES INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      4. CANDELA CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      5. CUTERA INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      6. CYNOSURE LLC
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      7. ENDO INTERNATIONAL PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      8. GALDERMA SA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      9. INCELER MEDIKAL CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      10. JOHNSON & JOHNSON
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      11. MERZ PHARMA GMBH & CO KGAA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      12. NUBWAY CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      13. SIENTRA INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCTS / SERVICES LIST
        4. STRENGTHS & CHALLENGES
      14. SINCLAIR PHARMA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      15. ZIMMER MEDIZINSYSTEME
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT

TABLE 2: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK

TABLE 11: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET

TABLE 12: LIST OF ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY TECHNOLOGY TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: KEY BUYING CRITERIA

FIGURE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022

FIGURE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 13: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 17: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 21: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 22: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 23: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 24: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 25: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 26: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 27: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 30: ABBVIE INC COMPANY PROFIT 2017 – 2021 ($ BILLION)

FIGURE 31: ABBVIE INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)

FIGURE 32: ABBVIE INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)

FIGURE 33: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 – 2021 ($ BILLION)

FIGURE 34: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)

FIGURE 35: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)

FIGURE 36: CUTERA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)

FIGURE 37: CUTERA INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)

FIGURE 38: CUTERA INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)

FIGURE 39: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 – 2021 ($ MILLION)

FIGURE 40: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)

FIGURE 41: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)

FIGURE 42: JOHNSON & JOHNSON COMPANY PROFIT 2017 – 2021 ($ BILLION)

FIGURE 43: JOHNSON & JOHNSON COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)

FIGURE 44: JOHNSON & JOHNSON COMPANY REVENUE – BY SEGMENT, 2021 (IN %)

FIGURE 45: JOHNSON & JOHNSON COMPANY REVENUE 2017 – 2021 ($ BILLION)

FIGURE 46: SIENTRA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)

FAQ’s